Incepta Side Meeting: Introducing the First Generic DMPA-SC

Incepta Pharmaceuticals

Fostering Reproductive Autonomy and choice: Introducing the First Generic DMPA-SC

Agora Bogotá Convention Center

In a move to advance women’s agency when it comes to contraceptive choice and reproductive health, <a href="https://www.inceptapharma.com/" title="https://www.inceptapharma.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Incepta Pharmaceuticals</a> has developed the first-ever WHO prequalified generic version of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) under the brand, Medogen SubQ.To celebrate this milestone, <a href="https://www.inceptapharma.com/" title="https://www.inceptapharma.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">Incepta Pharmaceuticals</a> will be a convening a side meeting at the upcoming International Conference of Family Planning, titled Fostering Reproductive Autonomy and Choice: Introducing the First Generic DMPA-SC. This session will take place in Room L.

Agenda

Breakfast will be served throughout the event, but we encourage you to arrive early to ensure you derive value from the entire event. 

Breakfast

Incepta Pharmaceuticals Side Meeting - Fostering Reproductive Autonomy and Choice: Introducing the First Generic DMPA-SC. 